Newsroom

Sorted by: Latest

-

Qube Research & Technologies LTD UK Regulatory Announcement: Form 8.3

LONDON--(BUSINESS WIRE)--  FORM 8.3 PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BY A PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORE Rule 8.3 of the Takeover Code (the “Code”) 1. KEY INFORMATION (a) Full name of discloser: Qube Research & Technologies Limited (b) Owner or controller of interests and short positions disclosed, if different from 1(a): The naming of nominee or vehicle companies is insufficient. For a trust, the trustee(s), settlor and beneficiari...
-

Hytera Advances AI-Powered Critical Communications at Global Partner Summit 2026

SHANGHAI--(BUSINESS WIRE)--Hytera Communications successfully concluded its annual Global Partner Summit (HGPS) 2026 on May 8 in Shanghai....
-

Delek Logistics Partners, LP and Delek Logistics Finance Corp. Announce Results of Tender Offer for Any and All of their Outstanding 7.125% Senior Notes due 2028

BRENTWOOD, Tenn--(BUSINESS WIRE)--Delek Logistics Partners, LP (NYSE: DKL) (“Delek Logistics”) and Delek Logistics Finance Corp., a subsidiary of Delek Logistics (together with Delek Logistics, the “Offerors”), announced today that they have received, as of 5:00 p.m., New York City time, on May 11, 2026 (the “Expiration Time”), tenders from holders of $270,721,000 in aggregate principal amount (excluding tenders through guaranteed delivery procedures), representing approximately 67.7%, of the O...
-

IHS Holding Limited Reports First Quarter 2026 Financial Results

LONDON--(BUSINESS WIRE)--IHS Holding Limited (NYSE: IHS) (“IHS Towers” or the “Company”), one of the largest independent owners, operators, and developers of shared communications infrastructure in the world by tower count, today reported financial results for the first quarter ended March 31, 2026. CONSOLIDATED HIGHLIGHTS – FIRST QUARTER 2026 The table below sets forth the select financial results for the three months ended March 31, 2026, and 2025:   Three months ended       March 31,   March...
-

DBGI Executes Apparel Licensing Partnership Through GCC Supporting Existing U.S. Program Deliveries up to $125 Million in Aggregate Value

AUSTIN, Texas--(BUSINESS WIRE)--DBGI Corp. (NASDAQ:DBGI) a publicly traded company specializing in eCommerce and Fashion today announced it has executed an apparel licensing program through GCC supporting existing U.S. program deliveries up to $125 million in potential aggregate contract value, subject to delivery orders, program requirements and customary conditions. Global Combat Collective (GCC) acts as a licensed commercial channel partner supporting product delivery opportunities associate...
-

733Park Advises Veero AI on Acquisition by Shirah Technologies in Vertical AI M&A Deal

BOSTON--(BUSINESS WIRE)--733Park, a top sell-side M&A advisor for AI, SaaS, fintech, and payments companies in the lower mid-market, today announced it served as exclusive sell-side M&A advisor to Veero AI, the Cambridge-based artificial intelligence and computer-vision company behind the EyeSize® virtual fitting platform, in its acquisition by Shirah Technologies, a SaaS and AI services company focused on leading e-commerce and direct-to-consumer brands. The transaction marks another v...
-

CP Group Adds 55 Allen Plaza in Downtown Atlanta to Growing Portfolio

ATLANTA--(BUSINESS WIRE)--CP Group, a prominent owner-operator of office properties throughout the Sunbelt, today announced it has been appointed as the third-party property manager and leasing advisor for 55 Allen Plaza, the 14-story Class-A office tower located at 55 Ivan Allen Jr. Boulevard NW in Downtown Atlanta. The assignment adds to CP Group's expansive Atlanta portfolio and brings the firm's signature tenant-centric management approach to this premier office address. “55 Allen Plaza has...
-

Unravel Biosciences Announces First Patient Dosed in RVL-001 Proof of Concept Studies for Rett Syndrome and Pitt Hopkins Syndrome

BOSTON--(BUSINESS WIRE)--Unravel Biosciences, Inc., ("Unravel"), a clinical stage therapeutics company established to advance drugs for complex diseases through its Predictable Medicine™ platform, today announced the first study participants have been dosed in Unravel’s RVL-001 clinical trials for Rett syndrome (“RTT”) and Pitt Hopkins syndrome (“PTHS”). RVL-001, a proprietary formulation of vorinostat, targets a novel therapeutic mechanism which will be clinically evaluated for the first time...
-

New Hertz Data Signals a Road Trip Renaissance, as 64% of Americans Plan to Hit the Road this Summer

ESTERO, Fla.--(BUSINESS WIRE)--Memorial Day weekend marks the unofficial start of summer travel season, and a new survey from Hertz shows Americans are doubling down on car travel, with 64% planning a road trip this summer. This resurgence reflects a growing desire to reclaim the road trip as an antidote to modern travel stress, embracing the freedom, flexibility and sense of control that driving brings to summer travel. As the country approaches its 250th anniversary, travelers are choosing ic...
-

Marchex Introduces Agent Behavior Solutions to Help Businesses Improve Sales Execution and Customer Experience

SEATTLE--(BUSINESS WIRE)--Marchex, Inc.™ (NASDAQ: MCHX), which harnesses the power of AI and conversation intelligence to provide actionable insights derived from prescriptive vertical-market data analytics, today launched Agent Behaviors, a new solution that delivers detailed agent performance analysis and recommendations to help franchises, dealers, and other organizations book more appointments, increase sales, and improve customer satisfaction. Agent performance has a direct impact on wheth...